Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations - 30/05/13
The National Scientific Research Fund (grant nos. OTKA-NKTH 80842 and OTKA K 100886) supported this work. |
|
Disclosure of potential conflict of interest: D. Csuka has received one or more payments for travel/accommodations/meeting expenses from CSL Behring, Viropharma, and Shire. H. Farkas has consultancy arrangements with Shire; has received one or more payments for lecturing from or is on the speakers’ bureau for Shire Human Genetic Therapies, Inc, Pharming, CSL Behring, and Viropharma; and has received one or more payments for travel/accommodations/meeting expenses from CSL Behring, Viropharma, and Shire. G. Füst has been supported by one or more grants from or has one or more grants pending with and has received one or more payments for travel/accommodations/meeting expenses from the National Research Fund. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 6
P. 1708 - juin 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?